A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

May 29, 2024

Primary Completion Date

August 30, 2026

Study Completion Date

August 30, 2026

Conditions
Headache Migraine Chronic
Interventions
DEVICE

Neurostimulator

Neurostimulation system that applies stimulation to nerve pathways in the head associated with migraine symptoms.

Trial Locations (20)

3170

RECRUITING

Monash House Research Centre, Melbourne

10019

RECRUITING

Northwell Health Physician Partners, New York

14226

RECRUITING

Dent Neurologic Institute, Amherst

17601

RECRUITING

Argires Marotti Neurological Associates, Lancaster

19107

RECRUITING

Jefferson Headache Center, Philadelphia

27103

RECRUITING

The Center for Clinical Research, Winston-Salem

28211

RECRUITING

Queen City Clinical Research, Charlotte

30265

RECRUITING

Vista Clinical Research and Summit Spine & Joint, Newnan

32224

RECRUITING

Mayo Clinic Florida, Jacksonville

55318

RECRUITING

iSpine Clinics, Chaska

55905

RECRUITING

Mayo Clinic Rochester, Rochester

72205

RECRUITING

University of Arkansas for Medical Sciences, Little Rock

75206

RECRUITING

Texas Neurology, Dallas

80218

RECRUITING

Barolat Neuroscience, Denver

85259

RECRUITING

Mayo Clinic Arizona, Scottsdale

92037

RECRUITING

UC San Diego Health, La Jolla

94558

RECRUITING

Neurovations, Napa

06106

RECRUITING

Ayer Neuroscience Institute Headache Center, Hartford

Unknown

RECRUITING

Genesis Research Services, Broadmeadow

RECRUITING

CerCare, Wayville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ShiraTronics

INDUSTRY

NCT06167655 - A PIVOTAL STUDY EVALUATING SAFETY AND EFFICACY OF THE SHIRATRONICS MIGRAINE THERAPY SYSTEM | Biotech Hunter | Biotech Hunter